Cari Meisel

Company: NanoTomer

Job title: Director of Research & Development

Seminars:

Simultaneous Treatment of Primary Solid Tumors, Metastatic Sites, & Tumor-draining Lymph Nodes Using a Non-traditional ADC to Target High Endothelial Venules 5:00 pm

Overview of HEVs as a novel, non-traditional target with a unique mechanism of action and strong therapeutic potential Evaluating concerns about off-target binding and toxicity Discussion of challenges and benefits of developing an IgM-format ADCRead more

day: Day Two